SCHEMBL15427152

SCHEMBL15427152

c1ccc2c(c1)oc1c(Nc3ccc4c(c3)OCO4)ncnc12

nearest known ligand 0.98

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.98
MEN1 O00255 9/20 0.98
KMT2A Q03164 9/20 0.98
MAPT P10636 9/20 0.98
NPC1 O15118 8/20 0.98
RAB9A P51151 8/20 0.98
SMN1; SMN2 Q16637 8/20 0.98
HPGD P15428 8/20 0.98
ALDH1A1 P00352 10/20 0.85
CLK1 P49759 2/20 0.70
NPSR1 Q6W5P4 2/20 0.69
L3MBTL1 Q9Y468 1/20 0.69
TSHR P16473 6/20 0.68
LMNA P02545 5/20 0.68
POLB P06746 4/20 0.68
HTT P42858 2/20 0.68
HSD17B10 Q99714 3/20 0.65
CASP3 P42574 2/20 0.65
SENP7 Q9BQF6 2/20 0.65
TDP1 Q9NUW8 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12307383 0.87 LMNA (0.81) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL12255947 0.85 LMNA (0.79) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL12306947 0.80 LMNA (0.77) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL15452556 0.80 KDM4E (1.00) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5564677 0.78 KDM4E (0.66) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL7216463 0.77 EGFR (1.00) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL15452470 0.77 MEN1 (0.98) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5569205 0.76 MAPT (0.60) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL15452557 0.75 NPC1 (1.00) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL15426110 0.74 NPC1 (0.77) KDM4EMEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9789111-B2 Casein kinase 1δ (CK 1δ) inhibitors ELECTROPHORETICS LIMITED (GB) 2017-10-17 US disclosed
US-9763947-B2 Casein kinase 1delta (CK1delta) inhibitors ELECTROPHORETICS LIMITED (GB) 2017-09-19 US disclosed
US-9763947-B2 Casein kinase 1delta (CK1delta) inhibitors ELECTROPHORETICS LIMITED (GB) 2017-09-19 US disclosed
US-20160058745-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS ELECTROPHORETICS LIMITED (GB) 2016-03-03 US disclosed
US-20160058745-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS ELECTROPHORETICS LIMITED (GB) 2016-03-03 US disclosed
EP-2651404-B1 CASEIN KINASE 1DELTA (CK1DELTA) INHIBITORS ELECTROPHORETICS LTD (GB) 2015-10-14 EP disclosed
US-20150209368-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS ELECTROPHORETICS LIMITED (GB) 2015-07-30 US disclosed
US-20140018540-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS ELECTROPHORETICS LIMITED 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018540-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS CSNK1G1, CSNK1A1, CSNK1D KDM4E 1362/4885MEN1 3434/4885KMT2A 695/4885
US-20150209368-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS CSNK1A1, CSNK1G1, CSNK1D KDM4E 1332/4885MEN1 3207/4885KMT2A 656/4885
US-20160058745-A1 CASEIN KINASE 1DELTA (CK 1DELTA) INHIBITORS CSNK1A1, CSNK1G1, CSNK1D KDM4E 1332/4885MEN1 3207/4885KMT2A 656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.